Panic Disorder clinical trials at UC Health
2 in progress, 1 open to eligible people
open to eligible people ages 18-65
The study will compare the effects that two different approaches of exposure therapy have on reducing fear and anxiety in individuals with social anxiety disorder or panic disorder.
Sorry, in progress, not accepting new patients
The purpose of this study is to provide some information (pilot data) about whether the study drug, suvorexant, (1) affects levels of orexin in people with panic disorder, and (2) is associated with decreased panic symptoms in response to a carbon dioxide (CO2) challenge.